QA: Kura Oncology Inc. in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001422143_2020_Kura_Oncology_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001422143')"}

Graph

Absolute values for 0001422143, Kura Oncology Inc.

  xvar xval
0 AssetsCurrent 239,603,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 44,000
3 remainder_Assets 2,325,000
4 LiabilitiesCurrent 15,564,000
5 LiabilitiesNoncurrent 7,627,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 19,653,000
9 ResearchAndDevelopmentExpense 47,826,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 4,339,000
13 remainder_ComprehensiveNetIncome 462,000
  yvar yval
0 Assets 241,972,000
1 Liabilities 23,191,000
2 Expenses 67,479,000
3 Revenues 0
4 StockholdersEquity 218,781,000
5 NetIncome -63,140,000
6 ComprehensiveNetIncome -62,909,000
7 BaseVar 168,721,500
8 EconomicCapitalRatio 2.36

Edgar->Model Mapping

Feature Distribution

Change over Time